课题基金 / 基金详情

DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria

DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
批准号:
EP/Y023528/1
负责人:
Stefano Pagliara
金额:
$215.83万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2024
资助国家:
英国
项目状态:
未结题
起止时间:
2024 至 --

项目摘要

项目成果

Stefano Pagliara的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DYNBIOTICS will determine the biophysical processes and molecular mechanisms that permit two genetically identical cells to accumulate substantially different quantities of a given compound. By controlling such mechanisms I will eradicate phenotypic bacterial variants that resist antibiotics causing drug treatment failure and life-threatening infectious diseases. Phenotypic antibiotic resistance is the non-heritable capability of bacterial subpopulations to transiently survive antibiotic treatment causing the recalcitrance of bacterial infections. There is an urgent need to develop antibiotic therapies against phenotypic resistant variants within populations of bacterial pathogens. This is particularly important in the case of ESKAPE pathogens that are in the WHO critical priority list since they represent a major cause of life-threatening infectious diseases and often resist antibiotic treatment. However, little is known about the impact of cell-to-cell differences in antibiotic accumulation on phenotypic antibiotic resistance because of a paucity of methods to characterise the dynamics of antibiotic accumulation at the level of the individual bacterium. Here I hypothesise that cell-to-cell differences in membrane transport drive bacterial phenotypic diversification in the absence of genetic variations. Using cutting-edge biophysical, omics and mathematical approaches, DYNBIOTICS will i) identify environmental factors that favour phenotypic heterogeneity in drug accumulation; ii) discover the biophysical processes and molecular mechanisms that permit phenotypic variants to avoid drug accumulation; iii) identify novel antibiotic-adjuvant combination therapies that enhance antibiotic accumulation in drug-resistant phenotypic variants. Achieving these aims is very timely given the current antibiotic resistance crisis: in order to fight pathogenic microbes we urgently need to make drugs accumulate at growth inhibitory levels in all cells within a population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ERADIAMR
  • 批准号:
    MR/Y033892/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $38.44万
  • 财政年份:
    2024
  • 负责人:
    Stefano Pagliara
  • 依托单位:
Understanding molecular accumulation in single cells via microfluidics and omics
  • 批准号:
    BB/V008021/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $65.26万
  • 财政年份:
    2021
  • 负责人:
    Stefano Pagliara
  • 依托单位:
国内基金
海外基金
Navigating Sustainability: Understanding Environm ent,Social and Governanc e Challenges and Solution s for Chinese Enterprises in Pakistan's CPEC Framew ork
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    Noshaba Aziz
  • 依托单位:
Understanding structural evolution of galaxies with machine learning
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    Nicola Rosario Napolitano
  • 依托单位:
Understanding complicated gravitational physics by simple two-shell systems
  • 批准号:
    12005059
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    国分隆文
  • 依托单位: